These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36889320)

  • 1. Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells.
    van der Werf I; Mondala PK; Steel SK; Balaian L; Ladel L; Mason CN; Diep RH; Pham J; Cloos J; Kaspers GJL; Chan WC; Mark A; La Clair JJ; Wentworth P; Fisch KM; Crews LA; Whisenant TC; Burkart MD; Donohoe ME; Jamieson CHM
    Cell Rep Med; 2023 Mar; 4(3):100962. PubMed ID: 36889320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML.
    Crews LA; Balaian L; Delos Santos NP; Leu HS; Court AC; Lazzari E; Sadarangani A; Zipeto MA; La Clair JJ; Villa R; Kulidjian A; Storb R; Morris SR; Ball ED; Burkart MD; Jamieson CHM
    Cell Stem Cell; 2016 Nov; 19(5):599-612. PubMed ID: 27570067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.
    Choudhary GS; Pellagatti A; Agianian B; Smith MA; Bhagat TD; Gordon-Mitchell S; Sahu S; Pandey S; Shah N; Aluri S; Aggarwal R; Aminov S; Schwartz L; Steeples V; Booher RN; Ramachandra M; Samson M; Carbajal M; Pradhan K; Bowman TV; Pillai MM; Will B; Wickrema A; Shastri A; Bradley RK; Martell RE; Steidl UG; Gavathiotis E; Boultwood J; Starczynowski DT; Verma A
    Elife; 2022 Aug; 11():. PubMed ID: 36040792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemia.
    Bamopoulos SA; Batcha AMN; Jurinovic V; Rothenberg-Thurley M; Janke H; Ksienzyk B; Philippou-Massier J; Graf A; Krebs S; Blum H; Schneider S; Konstandin N; Sauerland MC; Görlich D; Berdel WE; Woermann BJ; Bohlander SK; Canzar S; Mansmann U; Hiddemann W; Braess J; Spiekermann K; Metzeler KH; Herold T
    Leukemia; 2020 Oct; 34(10):2621-2634. PubMed ID: 32358566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.
    Hou HA; Liu CY; Kuo YY; Chou WC; Tsai CH; Lin CC; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Tien HF
    Oncotarget; 2016 Feb; 7(8):9084-101. PubMed ID: 26812887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of SF3B1 mutations in EVI1-rearranged myeloid neoplasms].
    Tanaka A
    Rinsho Ketsueki; 2023; 64(10):1258-1265. PubMed ID: 37914237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of malignant ADAR1 splice isoform switching with Rebecsinib.
    Crews LA; Ma W; Ladel L; Pham J; Balaian L; Steel SK; Mondala PK; Diep RH; Wu CN; Mason CN; van der Werf I; Oliver I; Reynoso E; Pineda G; Whisenant TC; Wentworth P; La Clair JJ; Jiang Q; Burkart MD; Jamieson CHM
    Cell Stem Cell; 2023 Mar; 30(3):250-263.e6. PubMed ID: 36803553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia.
    Figg JW; Barajas JM; Obeng EA
    Curr Opin Hematol; 2021 Mar; 28(2):73-79. PubMed ID: 33492002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.
    Maurin M; Ranjouri M; Megino-Luque C; Newberg JY; Du D; Martin K; Miner RE; Prater MS; Wee DKB; Centeno B; Pruett-Miller SM; Stewart P; Fleming JB; Yu X; Bravo-Cordero JJ; Guccione E; Black MA; Mann KM
    Nat Commun; 2023 Dec; 14(1):8444. PubMed ID: 38114498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution.
    Jiang Q; Isquith J; Ladel L; Mark A; Holm F; Mason C; He Y; Mondala P; Oliver I; Pham J; Ma W; Reynoso E; Ali S; Morris IJ; Diep R; Nasamran C; Xu G; Sasik R; Rosenthal SB; Birmingham A; Coso S; Pineda G; Crews L; Donohoe ME; Venter JC; Whisenant T; Mesa RA; Alexandrov LB; Fisch KM; Jamieson C
    Cell Rep; 2021 Jan; 34(4):108670. PubMed ID: 33503434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes.
    Brandsma AM; Bertrums EJM; van Roosmalen MJ; Hofman DA; Oka R; Verheul M; Manders F; Ubels J; Belderbos ME; van Boxtel R
    Blood Cancer Discov; 2021 Sep; 2(5):484-499. PubMed ID: 34642666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression.
    Wu B; Chen X; Pan X; Deng X; Li S; Wang Z; Wang J; Liao D; Xu J; Chen M; Zhao C; Xue Z; Wang Y; Niu T; Lin J; Chen L; Liu Y; Chen C
    PLoS Biol; 2023 May; 21(5):e3002088. PubMed ID: 37130348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
    Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
    Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
    Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
    Chianese U; Papulino C; Megchelenbrink W; Tambaro FP; Ciardiello F; Benedetti R; Altucci L
    Semin Cancer Biol; 2023 Jul; 92():84-101. PubMed ID: 37003397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBFOX2 alters splicing outcome in distinct binding modes with multiple protein partners.
    Zhou D; Couture S; Scott MS; Abou Elela S
    Nucleic Acids Res; 2021 Aug; 49(14):8370-8383. PubMed ID: 34244793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis.
    Luo CL; Xu XC; Liu CJ; He S; Chen JR; Feng YC; Liu SQ; Peng W; Zhou YQ; Liu YX; Wei PP; Li B; Mai HQ; Xia XJ; Bei JX
    Adv Sci (Weinh); 2021 Aug; 8(16):e2004852. PubMed ID: 34180133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hematological malignancies driven by aberrant splicing].
    Zang W; Saika W; Aoyama Y; Inoue D
    Rinsho Ketsueki; 2023; 64(9):875-883. PubMed ID: 37793861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing induces cytoplasmic localization of RBFOX2 protein in calcific tendinopathy.
    Cho N; Kim JO; Lee S; Choi S; Kim J; Ko MS; Park SJ; Ji JH; Kim KK
    Exp Mol Pathol; 2019 Aug; 109():36-41. PubMed ID: 31128090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
    Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
    Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.